相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety, Pharmacokinetics, and Activity of EZN-2208, a Novel Conjugate of Polyethylene Glycol and SN38, in Patients With Advanced Malignancies
Razelle Kurzrock et al.
CANCER (2012)
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
Puja Sapra et al.
ANGIOGENESIS (2011)
Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor
Fabio Pastorino et al.
CLINICAL CANCER RESEARCH (2010)
Dose-dependent association between UGT1A1*28 polymorphism and irinotecan-induced diarrhoea: A meta-analysis
Zhe-Yi Hu et al.
EUROPEAN JOURNAL OF CANCER (2010)
Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
Giuseppe Toffoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
Puja Sapra et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers
Hong Zhao et al.
BIOCONJUGATE CHEMISTRY (2008)
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11 - Refractory model
Puja Sapra et al.
CLINICAL CANCER RESEARCH (2008)
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening:: A double-blind, randomized, placebo-controlled study
Floris A. De Jong et al.
ONCOLOGIST (2006)
Maximum likelihood estimation in nonlinear mixed effects models
E Kuhn et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2005)
Prediction of irinotecan pharmacokinetics by use of cytochrome p450 3A4 phenotyping probes
RHJ Mathijssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model
HM Dodds et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
